Follow this preprint
Estimating seroprevalence of SARS-CoV-2 infection after a highly contagious Omicron outbreak: A cross sectional study in a university setting
View ORCID ProfileChing-Wen Hou, View ORCID ProfileStacy Williams, View ORCID ProfileGuillermo Trivino-Soto, Veronica Boyle, David Rainford, Selina Vicino, Mitch Magee, View ORCID ProfileYunro Chung, View ORCID ProfileJoshua LaBaer, View ORCID ProfileVel Murugan
doi: https://doi.org/10.1101/2023.08.29.23293775
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Ching-Wen Hou
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Stacy Williams
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Guillermo Trivino-Soto
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Veronica Boyle
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
David Rainford
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Selina Vicino
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Mitch Magee
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Yunro Chung
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
2College of Health Solutions, Arizona State University, Phoenix, AZ, USA
Joshua LaBaer
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA
Vel Murugan
1Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted August 29, 2023.
Estimating seroprevalence of SARS-CoV-2 infection after a highly contagious Omicron outbreak: A cross sectional study in a university setting
Ching-Wen Hou, Stacy Williams, Guillermo Trivino-Soto, Veronica Boyle, David Rainford, Selina Vicino, Mitch Magee, Yunro Chung, Joshua LaBaer, Vel Murugan
medRxiv 2023.08.29.23293775; doi: https://doi.org/10.1101/2023.08.29.23293775
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13259)
- Forensic Medicine (19)
- Gastroenterology (892)
- Genetic and Genomic Medicine (5072)
- Geriatric Medicine (471)
- Health Economics (774)
- Health Informatics (3199)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (515)
- Neurology (4829)
- Nursing (255)
- Nutrition (717)
- Oncology (2489)
- Ophthalmology (706)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1283)
- Primary Care Research (551)
- Public and Global Health (7391)
- Radiology and Imaging (1676)
- Respiratory Medicine (973)
- Rheumatology (474)
- Sports Medicine (416)
- Surgery (535)
- Toxicology (69)
- Transplantation (233)
- Urology (202)